Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Albacete – page 3

61 clinical trials in Albacete, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Albacete at a glance
61
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

61 trials in Albacete

Open in trial search

Aortic stenosis

Recruiting

Study on Ticagrelor and Aspirin for Patients with Severe Aortic Stenosis After Heart Valve Replacement

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fundacion Biomedica Galicia Sur
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Breast cancer

Recruiting

Long-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study of elranatamab, mezigdomide and dexamethasone in patients with relapsed/refractory multiple myeloma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Elranatamab
  • Sponsor:Fundacion PETHEMA

Rimonabant for Improving Cognitive Impairment in Patients with Post‑COVID‑19 Syndrome: A Randomized, Placebo‑Controlled Trial

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Acromegaly

Not yet recruiting

Short-Acting Pasireotide Test to Predict Treatment Response in Patients with Acromegaly

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pasireotide
  • Sponsor:Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol

Cerebrovascular accident

Not yet recruiting

Rimonabant for Improving Walking Ability in Post‑Stroke Patients in the Chronic Phase

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Cerebrovascular accident

Not yet recruiting

Effect of Rimonabant on Functional Recovery in Subacute Stroke Patients

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Acute myeloid leukaemia

Not yet recruiting

Tambiciclib Added to Venetoclax and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia in Patients Who Did Not Respond After Two Treatment Cycles

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:IIS La Fe

Seasonal allergy

Not yet recruiting

Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Phleum Pratense
  • Sponsor:Asac Pharmaceutical Inmunology S.A.

Infertility male

Not yet recruiting

Study of transdermal testosterone gel to improve ovarian response in women with low ovarian reserve and androgen receptor polymorphism undergoing fertility treatment

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Follitropin Alfa
  • Sponsor:Instituto Bernabeu S.L.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Albacete

What the registry says about research in the country

01 Neurological Conditions

Clinical trials focusing on acute ischemic stroke treatments and innovative therapies for multiple sclerosis. Research includes evaluation of novel compounds like sovateltide and studies on cognitive function in Huntington's Disease.

  • Stroke treatment optimization
  • Neurodegenerative diseases
  • Post-COVID cognitive impairment

Studies aim to improve patient outcomes and enhance neurological function recovery.

02 Oncology Research

Comprehensive studies on various cancer types, including breast cancer treatments and acute myeloid leukemia. Research focuses on targeted therapies and novel drug combinations.

  • Triple-negative breast cancer
  • Leukemia treatments
  • Immunotherapy approaches

Investigations aim to improve survival rates and treatment effectiveness.

03 Cardiovascular Studies

Research on coronary artery conditions and treatment strategies for various cardiac disorders. Studies include evaluation of antiplatelet agents and innovative approaches to pulmonary embolism.

  • Arterial dissection treatments
  • Platelet inhibition strategies
  • Heart failure management

Focus on improving cardiac care outcomes and patient safety.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.